J&J Beats $600M Stent Patent Verdict For Good
The U.S. Supreme Court on Monday refused to revisit a Federal Circuit ruling that Johnson & Johnson did not infringe a doctor's stent patent, conclusively freeing the company from a jury...To view the full article, register now.
Already a subscriber? Click here to view full article